Umstellung antithrombozytärer Therapien: Interaktionen und praktische Durchführung – DGK-Empfehlung : : aus der Kommission für Klinische Praxis und Leitlinien in Kooperation mit der Arbeitsgruppe Kardiovaskuläre Hämostase und antithrombotische Therapie (AG19), der Arbeitsgruppe Klinische Pharmakologie (AG 22) und der Arbeitsgruppe Interventionelle Kardiologie (AG 6) - AGIK = Switching antithrombotic therapy: Drug interactions and practical implementation- recommendations of the German Cardiac Society (DGK) : from the Committee for Clinical Practice and Guidelines in cooperation with the Working Group on Cardiovascular Hemostasis and Antithrombotic Therapy (AG19), the Working Group on Clinical Pharmacology (AG22) and the Working Group on Interventional Cardiology (AG6) - AGIK

Related documents

• Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel#805597
• Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus#865608
• Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS#805811
• Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI#1060096
• A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy#881623